[NO and atherosclerosis]

MeSH terms

• Angiotensin-Converting Enzyme Inhibitors / pharmacology
• Angiotensin-Converting Enzyme Inhibitors / therapeutic use
• Animals
• Antioxidants / pharmacology
• Antioxidants / therapeutic use
• Arginine / therapeutic use
• Arteriosclerosis / drug therapy
• Arteriosclerosis / etiology*
• Arteriosclerosis / physiopathology
• Endothelium, Vascular / physiopathology
• Enzyme Inhibitors / pharmacology
• Genetic Therapy
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
• Hyperlipidemias / complications
• Hypertension / complications
• NG-Nitroarginine Methyl Ester / pharmacology
• Nitric Oxide / biosynthesis
• Nitric Oxide / physiology*
• Nitric Oxide / therapeutic use
• Nitric Oxide Donors / therapeutic use
• Nitric Oxide Synthase / deficiency
• Nitric Oxide Synthase / genetics
• Nitric Oxide Synthase / physiology
• Nitric Oxide Synthase Type III
• Probucol / pharmacology
• Probucol / therapeutic use
• Risk Factors
• Stress, Mechanical